Viewing StudyNCT00006291



Ignite Creation Date: 2024-05-05 @ 9:42 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006291
Status: COMPLETED
Last Update Posted: 2021-11-01
First Post: 2000-09-22

Brief Title: Safety and Effectiveness of Adding Either an HIV Vaccine Interleukin-2 or Both to a Patients Anti-HIV Drug Combination
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
HIV Therapeutic Vaccine View
Virus Replication View
T-Lymphocytes View
Lymphocyte Transformation View
AIDS Vaccines View
Anti-HIV Agents View
Viral Load View
Aldesleukin View